ResMed Inc.
RMDHealthcareNASDAQMedical Instruments & Supplies · Last scanned May 30, 2026
Scan Results
Daily timeframePart of the healthcare sector, ResMed Inc. (RMD) is listed under Medical Instruments & Supplies. The company carries a $27.64B market cap, placing it firmly in the large-cap category. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software.
Market Cap
$27.64B
Beta
0.84
P/E (TTM)
18.38
P/E (Fwd)
15.62
EPS (TTM)
$10.37
EPS (Fwd)
$12.20
ROE
25.3%
ROA
14.7%
Cash
$1.66B
Total Debt
$843.2M
Free CF
$1.45B
52W Change
-21.9%
Annual Financials
Cash vs Debt
ResMed Inc. holds $1.66B in cash against $843.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $1.45B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 25.2%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 14.7% further supports the picture of efficient asset utilization. Revenue has grown from $3.58B (2022) to $5.15B (2025), reflecting a 44% increase over the period.
Investors considering ResMed Inc. should weigh the typical risks associated with RMD's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence ResMed Inc.'s trajectory.